These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2099235)

  • 1. [Comparative evaluation of the gastric transit of floating and non-floating matrix dosage forms].
    Timmermans J
    Bull Mem Acad R Med Belg; 1990; 145(8-9):365-75. PubMed ID: 2099235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastroretentive dosage forms.
    Moës AJ
    Crit Rev Ther Drug Carrier Syst; 1993; 10(2):143-95. PubMed ID: 8370085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific aspects of gastro-intestinal transit in children for drug delivery design.
    Bowles A; Keane J; Ernest T; Clapham D; Tuleu C
    Int J Pharm; 2010 Aug; 395(1-2):37-43. PubMed ID: 20478372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and evaluation of new sustained-release floating microspheres.
    Ma N; Xu L; Wang Q; Zhang X; Zhang W; Li Y; Jin L; Li S
    Int J Pharm; 2008 Jun; 358(1-2):82-90. PubMed ID: 18407442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo evaluation of riboflavin-containing microballoons for a floating controlled drug delivery system in healthy humans.
    Sato Y; Kawashima Y; Takeuchi H; Yamamoto H
    Int J Pharm; 2004 May; 275(1-2):97-107. PubMed ID: 15081141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors controlling the buoyancy and gastric retention capabilities of floating matrix capsules: new data for reconsidering the controversy.
    Timmermans J; Moës AJ
    J Pharm Sci; 1994 Jan; 83(1):18-24. PubMed ID: 8138903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of the gastric residence time of magnetic dosage forms using the Heidelberg capsule.
    Groning R; Berntgen M
    Pharmazie; 1996 May; 51(5):328-31. PubMed ID: 8710954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the gastrointestinal transit and disintegration behavior of floating and sinking acid-resistant capsules using a novel MRI labeling technique.
    Grimm M; Ball K; Scholz E; Schneider F; Sivert A; Benameur H; Kromrey ML; Kühn JP; Weitschies W
    Eur J Pharm Sci; 2019 Mar; 129():163-172. PubMed ID: 30639530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastroretentive dosage forms: overview and special case of Helicobacter pylori.
    Bardonnet PL; Faivre V; Pugh WJ; Piffaretti JC; Falson F
    J Control Release; 2006 Mar; 111(1-2):1-18. PubMed ID: 16403588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behaviour and transit of tamsulosin Oral Controlled Absorption System in the gastrointestinal tract.
    Stevens HN; Speakman M
    Curr Med Res Opin; 2006 Dec; 22(12):2323-8. PubMed ID: 17257446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microspheres as floating drug-delivery systems to increase gastric retention of drugs.
    Soppimath KS; Kulkarni AR; Rudzinski WE; Aminabhavi TM
    Drug Metab Rev; 2001 May; 33(2):149-60. PubMed ID: 11495501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gastroretentive dosage forms].
    Kiss D; Zelkó R
    Acta Pharm Hung; 2005; 75(3):169-76. PubMed ID: 16318241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site-specific drug delivery systems within the gastro-intestinal tract: from the mouth to the colon.
    Pinto JF
    Int J Pharm; 2010 Aug; 395(1-2):44-52. PubMed ID: 20546856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric retentive drug-delivery systems.
    Hwang SJ; Park H; Park K
    Crit Rev Ther Drug Carrier Syst; 1998; 15(3):243-84. PubMed ID: 9699081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium silicate based microspheres of repaglinide for gastroretentive floating drug delivery: preparation and in vitro characterization.
    Jain SK; Awasthi AM; Jain NK; Agrawal GP
    J Control Release; 2005 Oct; 107(2):300-9. PubMed ID: 16095748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Floating microspheres bearing acetohydroxamic acid for the treatment of Helicobacter pylori.
    Umamaheshwari RB; Jain S; Bhadra D; Jain NK
    J Pharm Pharmacol; 2003 Dec; 55(12):1607-13. PubMed ID: 14738585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioisotope evidence of varying transit of solid food in gastrectomized patients with and without dumping syndrome.
    Palermo F; Boccaletto F; Magalini M; Chiara G; Tommaseo T; Dapporto L
    Nuklearmedizin; 1988 Oct; 27(5):195-9. PubMed ID: 3194231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastroretentive delivery systems: a mini review.
    Talukder R; Fassihi R
    Drug Dev Ind Pharm; 2004; 30(10):1019-28. PubMed ID: 15595568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alginate microspheres of isoniazid for oral sustained drug delivery.
    Rastogi R; Sultana Y; Aqil M; Ali A; Kumar S; Chuttani K; Mishra AK
    Int J Pharm; 2007 Apr; 334(1-2):71-7. PubMed ID: 17113732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of sustained release gastroretentive drug delivery system for ofloxacin: in vitro and in vivo evaluation.
    Chavanpatil M; Jain P; Chaudhari S; Shear R; Vavia P
    Int J Pharm; 2005 Nov; 304(1-2):178-84. PubMed ID: 16198522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.